J.M. Metselaar (Josbert)


Pharmaceutical Preparations


Chen, Y., Tezcan, O., Li, D., Beztsinna, N., Lou, B., Etrych, T., ... Hennink, W. E. (2017). Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin. Nanoscale, 9(29), 10404-10419. DOI: 10.1039/c7nr03592f
Geest, T., Laverman, P., Gerrits, D., Walgreen, B., Helsen, M. M., Klein, C., ... Boerman, O. C. (2017). Liposomal treatment of experimental arthritis can be monitored noninvasively with a radiolabeled anti-fibroblast activation protein antibody. Journal of nuclear medicine, 58(1), 151-155. DOI: 10.2967/jnumed.116.177931
Alaarg, A., Pérez-Medina, C., Metselaar, J. M., Nahrendorf, M., Fayad, Z. A., Storm, G., & Mulder, W. J. M. (2017). Applying nanomedicine in maladaptive inflammation and angiogenesis. Advanced drug delivery reviews, 119, 143-158. DOI: 10.1016/j.addr.2017.05.009
Alaarg, A., Senders, M. L., Varela-Moreira, A., Pérez-Medina, C., Zhao, Y., Tang, J., ... Storm, G. (2017). A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis. Journal of controlled release, 262, 47-57. DOI: 10.1016/j.jconrel.2017.07.013
Van Der Meer, L. T., Terry, S. Y. A., Van Ingen Schenau, D. S., Andree, K. C., Franssen, G. M., Roeleveld, D. M., ... van Leeuwen, F. N. (2017). In vivo imaging of antileukemic drug asparaginase reveals a rapid macrophage-mediated clearance from the bone marrow. Journal of nuclear medicine, 58(2), 214-220. DOI: 10.2967/jnumed.116.177741
Allijn, I. E., Czarny, B. M. S., Wang, X., Chong, S. Y., Weiler, M., Eduardo Da Silva, A., ... Schiffelers, R. M. (2017). Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. Journal of controlled release, 247, 127-133. DOI: 10.1016/j.jconrel.2016.12.042
Kroon, J., Kroon, J., Puhr, M., Buijs, J. T., van der Horst, G., Hemmer, D. M., ... van der Pluijm, M. (2016). Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocrine-related cancer, 23(1), 35-45. DOI: 10.1530/ERC-15-0343

UT Research Information System

Contact Details

Visiting Address

University of Twente
Drienerlolaan 5
7522 NB Enschede
The Netherlands

Navigate to location

Mailing Address

University of Twente
P.O. Box 217
7500 AE Enschede
The Netherlands